Is CBD Safe? The FDA Can't Say
Short Wave
00:00
Navigating CBD's Regulatory Maze
This chapter delves into the regulatory complexities of CBD in the U.S., examining the FDA's cautious approach due to insufficient safety data. It contrasts the FDA's hesitance with the World Health Organization's favorable assessment, highlighting the need for further research to ensure public safety amidst a burgeoning market.
Play episode from 03:17
Transcript
